Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention.

OBJECTIVES We compared intravascular ultrasound (IVUS) and 2 different generations of optical coherence tomography (OCT)-time-domain OCT (TD-OCT) and frequency-domain OCT (FD-OCT)-for the assessment of coronary disease and percutaneous coronary intervention (PCI) using stents. BACKGROUND OCT is a promising light-based intravascular imaging modality with higher resolution than IVUS. However, the paucity of data on OCT image quantification has limited its application in clinical practice. METHODS A total of 227 matched OCT and IVUS pull backs were studied. One hundred FD-OCT and IVUS pull backs in nonstented (n = 56) and stented (n = 44) vessels were compared. Additionally, 127 matched TD-OCT and IVUS images were compared in stented vessels. RESULTS FD-OCT depicted more severe native coronary disease than IVUS; minimal lumen area (MLA) was 2.33 ± 1.56 mm(2) versus 3.32 ± 1.92 mm(2), respectively (p < 0.001). Reference vessel dimensions were equivalent between FD-OCT and IVUS in both native and stented coronaries, but TD-OCT detected smaller reference lumen size compared with IVUS. Immediately post-PCI, in-stent MLAs were similar between FD-OCT and IVUS, but at follow-up, both FD-OCT and TD-OCT detected smaller MLAs than did IVUS, likely due to better detection of neointimal hyperplasia (NIH). Post-PCI malapposition and tissue prolapse were more frequently identified by FD-OCT. CONCLUSIONS FD-OCT generates similar reference lumen dimensions but higher degrees of disease severity and NIH, as well as better detection of malapposition and tissue prolapse compared with IVUS. First-generation TD-OCT was associated with smaller reference vessel dimensions compared with IVUS.

[1]  P. Serruys,et al.  Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. , 2009, Revista espanola de cardiologia.

[2]  Joanna J Wykrzykowska,et al.  First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[3]  P. Serruys,et al.  The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. , 2010, European heart journal.

[4]  Giuseppe Biondi-Zoccai,et al.  Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. , 2010, JACC. Cardiovascular interventions.

[5]  T. Stijnen,et al.  Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. , 2010, European heart journal.

[6]  E. Halpern,et al.  Evaluation of intracoronary stenting by intravascular optical coherence tomography , 2003, Heart.

[7]  Paul G Yock,et al.  In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. , 2008, JACC. Cardiovascular interventions.

[8]  A. Rollins,et al.  Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. , 2009, JACC. Cardiovascular interventions.

[9]  P. Serruys,et al.  Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries , 2003, Circulation.

[10]  P. Teirstein,et al.  A Randomized Controlled Trial of Angiography Versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial) , 2009, Circulation. Cardiovascular interventions.

[11]  H. Bezerra,et al.  In vitro validation of new Fourier-domain optical coherence tomography. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  P. Teirstein,et al.  Percutaneous coronary intervention use in the United States: defining measures of appropriateness. , 2012, JACC. Cardiovascular interventions.

[13]  Patrick W. Serruys,et al.  Comparación cuantitativa ex vivo e in vivo de las dimensiones del lumen medidas por tomografía de coherencia óptica y ecografía intravascular en arterias coronarias humanas , 2009 .

[14]  G. Mintz,et al.  The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial. , 2001, European heart journal.

[15]  P. Fitzgerald,et al.  Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. , 2004, Journal of the American College of Cardiology.

[16]  Y. Neishi,et al.  Assessment of the coronary calcification by optical coherence tomography. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  Steven E. Nissen,et al.  Intravascular Ultrasound Assessment of Lumen Size and Wall Morphology in Normal Subjects and Patients With Coronary Artery Disease , 1991, Circulation.

[18]  J. Moses,et al.  Does the specific intravascular ultrasound criterion used to optimize stent expansion have an impact on the probability of stent restenosis? , 1999, The American journal of cardiology.

[19]  P. Serruys,et al.  Vascular Tissue Reaction to Acute Malapposition in Human Coronary Arteries: Sequential Assessment With Optical Coherence Tomography , 2012, Circulation. Cardiovascular interventions.

[20]  Patrick W Serruys,et al.  Reproducibility of quantitative optical coherence tomography for stent analysis. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  Hiroyuki Kyono,et al.  Assessment of coronary stent by optical coherence tomography, methodology and definitions , 2011, The International Journal of Cardiovascular Imaging.

[22]  N. Weissman,et al.  Predictors of Subacute Stent Thrombosis: Results of a Systematic Intravascular Ultrasound Study , 2003, Circulation.

[23]  Giulio Guagliumi,et al.  Optical coherence tomography: High resolution intravascular imaging to evaluate vascular healing after coronary stenting , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  Akiko Maehara,et al.  Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. , 2009, JACC. Cardiovascular interventions.

[25]  P Hall,et al.  Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. , 1995, Circulation.

[26]  Hiromasa Otake,et al.  Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. , 2007, European heart journal.

[27]  Hiroto Tsujioka,et al.  Advantage of next‐generation frequency‐domain optical coherence tomography compared with conventional time‐domain system in the assessment of coronary lesion , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[28]  F. Fernández‐Avilés,et al.  Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. , 2006, Journal of the American College of Cardiology.